IL160641A0 - Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them - Google Patents
Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing themInfo
- Publication number
- IL160641A0 IL160641A0 IL16064102A IL16064102A IL160641A0 IL 160641 A0 IL160641 A0 IL 160641A0 IL 16064102 A IL16064102 A IL 16064102A IL 16064102 A IL16064102 A IL 16064102A IL 160641 A0 IL160641 A0 IL 160641A0
- Authority
- IL
- Israel
- Prior art keywords
- binding domain
- therapeutic
- delivery
- agents
- fusion proteins
- Prior art date
Links
Classifications
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H17/00—Non-fibrous material added to the pulp, characterised by its constitution; Paper-impregnating material characterised by its constitution
- D21H17/20—Macromolecular organic compounds
- D21H17/21—Macromolecular organic compounds of natural origin; Derivatives thereof
- D21H17/22—Proteins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/24—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing ingredients to enhance the sticking of the active ingredients
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
- A01N25/28—Microcapsules or nanocapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L2300/256—Antibodies, e.g. immunoglobulins, vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/258—Genetic materials, DNA, RNA, genes, vectors, e.g. plasmids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/622—Microcapsules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Agronomy & Crop Science (AREA)
- Zoology (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Environmental Sciences (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01308467 | 2001-10-03 | ||
PCT/EP2002/010523 WO2003031477A1 (en) | 2001-10-03 | 2002-09-19 | Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
IL160641A0 true IL160641A0 (en) | 2004-07-25 |
Family
ID=8182323
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16064102A IL160641A0 (en) | 2001-10-03 | 2002-09-19 | Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
IL160641A IL160641A (en) | 2001-10-03 | 2004-02-26 | Method of delivering an agrochemical benefit agent to a site in or on a plant |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL160641A IL160641A (en) | 2001-10-03 | 2004-02-26 | Method of delivering an agrochemical benefit agent to a site in or on a plant |
Country Status (10)
Country | Link |
---|---|
US (1) | US20050107256A1 (xx) |
EP (1) | EP1432738B1 (xx) |
JP (1) | JP4537060B2 (xx) |
AT (1) | ATE424418T1 (xx) |
AU (1) | AU2002333865B2 (xx) |
CA (1) | CA2458392A1 (xx) |
DE (1) | DE60231417D1 (xx) |
DK (1) | DK1432738T3 (xx) |
IL (2) | IL160641A0 (xx) |
WO (1) | WO2003031477A1 (xx) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1627049T3 (da) | 2003-05-29 | 2010-05-31 | Genencor Int | Nye Trichoderma-gener |
US7285264B2 (en) | 2003-09-08 | 2007-10-23 | E.I. Du Pont De Nemours And Company | Peptide-based body surface coloring reagents |
US7585495B2 (en) | 2003-09-08 | 2009-09-08 | E. I. Du Pont De Nemours And Company | Method for identifying shampoo-resistant hair-binding peptides and hair benefit agents therefrom |
US7220405B2 (en) | 2003-09-08 | 2007-05-22 | E. I. Du Pont De Nemours And Company | Peptide-based conditioners and colorants for hair, skin, and nails |
US7807141B2 (en) | 2003-09-08 | 2010-10-05 | E.I. Du Pont De Nemours And Company | Peptide-based oral care surface reagents for personal care |
WO2006034227A2 (en) * | 2004-09-20 | 2006-03-30 | California Pacific Medical Center | Face mask |
US7736633B2 (en) | 2005-09-28 | 2010-06-15 | E.I. Du Pont De Nemours And Company | Method for enhancing effects of colorants and conditioners |
US7858581B2 (en) | 2005-12-15 | 2010-12-28 | E. I. Du Pont De Nemours And Company | PMMA binding peptides and methods of use |
US7700716B2 (en) | 2005-12-15 | 2010-04-20 | E. I. Du Pont De Nemours And Company | Polytetrafluoroethylene binding peptides and methods of use |
US7632919B2 (en) | 2005-12-15 | 2009-12-15 | E.I. Du Pont De Nemours And Company | Polystyrene binding peptides and methods of use |
US7709601B2 (en) | 2005-12-15 | 2010-05-04 | E. I. Du Pont De Nemours And Company | Nylon binding peptides and methods of use |
US7906617B2 (en) | 2005-12-15 | 2011-03-15 | E. I. Du Pont De Nemours And Company | Polyethylene binding peptides and methods of use |
US7928076B2 (en) | 2005-12-15 | 2011-04-19 | E. I. Du Pont De Nemours And Company | Polypropylene binding peptides and methods of use |
US9249202B2 (en) | 2006-08-11 | 2016-02-02 | Life Sciences Research Partners Vzw | Immunogenic peptides and their use in immune disorders |
US8999346B2 (en) * | 2008-02-14 | 2015-04-07 | Life Sciences Research Partners Vzw | Immunogenic control of tumours and tumour cells |
ES2650236T3 (es) | 2008-02-14 | 2018-01-17 | Life Sciences Research Partners Vzw | Linfocitos T CD4+ con propiedades citolíticas |
EP2719396B1 (en) | 2008-02-14 | 2017-06-21 | Life Sciences Research Partners VZW | Immunotherapy targeting intracellular pathogens |
EP2623125A1 (en) | 2008-02-14 | 2013-08-07 | Life Sciences Research Partners VZW | Elimination of immune responses to viral vectors |
US8716001B2 (en) | 2009-02-06 | 2014-05-06 | Cornell University | Trichoderma strains that induce resistance to plant diseases and/or increase plant growth |
US8481678B2 (en) | 2009-03-30 | 2013-07-09 | E I Du Pont De Nemours And Company | Peptide-based tooth whitening reagents |
CA2795480C (en) | 2010-04-06 | 2021-10-26 | Vrije Universiteit Brussel | Specific delivery of agrochemicals |
EP2609119B1 (en) * | 2010-08-26 | 2017-10-18 | Agrosavfe N.V. | Chitinous polysaccharide antigen binding proteins |
CA2820617C (en) | 2010-11-25 | 2020-01-07 | Imnate Sarl | Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination |
JP2012246227A (ja) * | 2011-05-25 | 2012-12-13 | Mie Univ | 土壌病害防除剤、及びこの防除剤を用いた土壌病害防除方法 |
CA2851040A1 (en) | 2011-10-06 | 2013-04-11 | Agrosavfe N.V. | Manufacturing of specifically targeting microcapsules |
GB201201511D0 (en) | 2012-01-30 | 2012-03-14 | Univ Leuven Kath | Modified epitopes for boosting CD4+ T-cell responses |
GB201309469D0 (en) | 2013-05-28 | 2013-07-10 | Imcyse Sa | Detection of CD4+ T lymphocytes |
US20170223964A1 (en) | 2014-04-17 | 2017-08-10 | Basf Se | Combination of Novel Nitrification Inhibitors and Herbicides as Well as Combination of (Thio)Phosphoric Acid Triamides and Herbicides |
CN106470962A (zh) | 2014-04-17 | 2017-03-01 | 巴斯夫欧洲公司 | 新型硝化抑制剂和生物农药的组合以及(硫代)磷酸三酰胺和生物农药的组合 |
US10556844B2 (en) | 2015-02-06 | 2020-02-11 | Basf Se | Pyrazole compounds as nitrification inhibitors |
CA2983964A1 (en) | 2015-05-12 | 2016-11-17 | Basf Se | Thioether compounds as nitrification inhibitors |
US10729791B2 (en) | 2015-05-18 | 2020-08-04 | Imcyse Sa | Animal models for evaluating pharmaceutical compounds |
CA2995771A1 (en) | 2015-09-25 | 2017-03-30 | Imcyse Sa | Improved methods and compounds for eliminating immune responses to therapeutic agents |
SG11201808710UA (en) | 2016-04-19 | 2018-11-29 | Imcyse Sa | Novel immunogenic cd1d binding peptides |
CA3024100A1 (en) | 2016-05-18 | 2017-11-23 | Basf Se | Capsules comprising benzylpropargylethers for use as nitrification inhibitors |
IL275726B1 (en) | 2018-01-09 | 2024-02-01 | Basf Se | Hetaryl silylethynyl compounds as nitrification inhibitors |
PE20211753A1 (es) | 2018-02-28 | 2021-09-06 | Basf Se | Uso de alcoxipirazoles como inhibidores de la nitrificacion |
WO2019166558A1 (en) | 2018-02-28 | 2019-09-06 | Basf Se | Use of pyrazole propargyl ethers as nitrification inhibitors |
KR20200128405A (ko) | 2018-02-28 | 2020-11-12 | 바스프 에스이 | 질화작용 저해제로서의 n-관능화 알콕시 피라졸 화합물의 용도 |
WO2020002472A1 (en) | 2018-06-28 | 2020-01-02 | Basf Se | Use of alkynylthiophenes as nitrification inhibitors |
WO2020020777A1 (en) | 2018-07-23 | 2020-01-30 | Basf Se | Use of substituted 2-thiazolines as nitrification inhibitors |
CN112424147B (zh) | 2018-07-23 | 2023-06-30 | 巴斯夫欧洲公司 | 取代噻唑烷化合物作为硝化抑制剂的用途 |
EP4288398A1 (en) | 2021-02-02 | 2023-12-13 | Basf Se | Synergistic action of dcd and alkoxypyrazoles as nitrification inhibitors |
EP4049749A1 (en) * | 2021-02-25 | 2022-08-31 | Basf Se | New microcapsules containing active substances |
AR125955A1 (es) | 2021-05-21 | 2023-08-30 | Basf Se | Uso de un compuesto de alcoxi pirazol n-funcionalizado como inhibidor de nitrificación |
CA3219022A1 (en) | 2021-05-21 | 2022-11-24 | Barbara Nave | Use of ethynylpyridine compounds as nitrification inhibitors |
EP4347624A1 (en) * | 2021-06-04 | 2024-04-10 | University of Copenhagen | Peptides with mucin-binding properties |
CN117500377A (zh) | 2021-06-21 | 2024-02-02 | 巴斯夫欧洲公司 | 具有基于吡唑的构建单元的金属有机框架 |
WO2023118418A1 (en) | 2021-12-23 | 2023-06-29 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | A novel glv-phenolamide: biosynthesis and function in protecting plants from herbivore attack |
WO2023203066A1 (en) | 2022-04-21 | 2023-10-26 | Basf Se | Synergistic action as nitrification inhibitors of dcd oligomers with alkoxypyrazole and its oligomers |
WO2024079210A1 (en) * | 2022-10-14 | 2024-04-18 | Bactolife A/S | sdAb-CBM FUSION PROTEIN BOUND TO POLYSACCHARIDE POLYMER |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5137819A (en) * | 1988-07-08 | 1992-08-11 | University Of British Columbia | Cellulose binding fusion proteins for immobilization and purification of polypeptides |
US5496934A (en) * | 1993-04-14 | 1996-03-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Nucleic acids encoding a cellulose binding domain |
BR9813358A (pt) * | 1998-01-16 | 2000-10-03 | Unilever Nv | Conjugado de polissacarìdeo, produto, e, processo de ligação de marcação de uma entidade à celulose |
WO1999057154A1 (en) * | 1998-05-01 | 1999-11-11 | The Procter & Gamble Company | Fabric care compositions comprising cellulose binding domains |
WO1999057155A1 (en) * | 1998-05-01 | 1999-11-11 | The Procter & Gamble Company | Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein |
ATE307871T1 (de) * | 1999-12-22 | 2005-11-15 | Unilever Nv | Verfahren zur behandlung von gewebe |
BR0016570A (pt) * | 1999-12-22 | 2002-10-01 | Unilever Nv | Proteìna de fusão, composição detergente, e, processo para fornecer um agente de benefìcio a um tecido |
-
2002
- 2002-09-19 WO PCT/EP2002/010523 patent/WO2003031477A1/en active Application Filing
- 2002-09-19 CA CA002458392A patent/CA2458392A1/en not_active Abandoned
- 2002-09-19 JP JP2003534459A patent/JP4537060B2/ja not_active Expired - Fee Related
- 2002-09-19 AT AT02800565T patent/ATE424418T1/de not_active IP Right Cessation
- 2002-09-19 EP EP02800565A patent/EP1432738B1/en not_active Expired - Lifetime
- 2002-09-19 DE DE60231417T patent/DE60231417D1/de not_active Expired - Lifetime
- 2002-09-19 DK DK02800565T patent/DK1432738T3/da active
- 2002-09-19 US US10/491,649 patent/US20050107256A1/en not_active Abandoned
- 2002-09-19 IL IL16064102A patent/IL160641A0/xx unknown
- 2002-09-19 AU AU2002333865A patent/AU2002333865B2/en not_active Ceased
-
2004
- 2004-02-26 IL IL160641A patent/IL160641A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK1432738T3 (da) | 2009-05-25 |
EP1432738B1 (en) | 2009-03-04 |
ATE424418T1 (de) | 2009-03-15 |
IL160641A (en) | 2010-11-30 |
EP1432738A1 (en) | 2004-06-30 |
JP2005520789A (ja) | 2005-07-14 |
JP4537060B2 (ja) | 2010-09-01 |
WO2003031477A1 (en) | 2003-04-17 |
US20050107256A1 (en) | 2005-05-19 |
AU2002333865B2 (en) | 2006-02-23 |
CA2458392A1 (en) | 2003-04-17 |
DE60231417D1 (de) | 2009-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL160641A0 (en) | Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them | |
GB2335357A (en) | Chitosan-gelatin A microparticles | |
GEP20012442B (en) | Irreversible Inhibitors of Tyrosine Kinases | |
DZ2494A1 (fr) | Composition pharmaceutique d'oméprazole. | |
ES2130428T3 (es) | Cristales de insulina asp-b28. | |
GEP20063741B (en) | Nonaryl-Heterocyclic NMDA/NR2B Antagonists | |
BR9804500B1 (pt) | derivado de amida, referida composição farmacêutica e agente terapêutico. | |
WO2002085299A3 (en) | Therapeutic treatments using the direct application of antimicrobial metal compositions | |
BR9812634A (pt) | April - uma proteìna com efeitos de crescimento | |
FR2825277B1 (fr) | Composition cosmetique et/ou dermatologique et/ou pharmaceutique contenant au moins un compose ihnibiteur de l'enzime 3, b-hsd | |
ATE345133T1 (de) | Laktose-freie, nicht-hygroskopische und wasserfreie pharmazeutische zusammensetzungen von descarboethoxyloratadin | |
WO2001034641A8 (en) | Antimicrobial activity of the first cationic cluster of human lactoferrin | |
WO2003020963A3 (en) | Proteins in type 2 diabetes | |
PT1228039E (pt) | N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas | |
HUP9802897A3 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
AU8851298A (en) | L-threonate ferrous, as well as pharmaceutical composition and use for improvingand treating human anemia thereof | |
ATE128862T1 (de) | Zusammensetzung zur lokalen anwendung. | |
ATE245998T1 (de) | Somatostatin agoniste zur reduzierung von körpergewicht | |
BG103905A (en) | New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine | |
FR2804601B1 (fr) | Dispositif d'application de principes actifs utilisables dans le domaine pharmaceutique ou cosmetique | |
AU2002238673A1 (en) | Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof | |
AU8387601A (en) | Novel pharmaceutical composition for the topical application of water-insoluble and/or hardly water-soluble active agents | |
ATE459376T1 (de) | Pharmazeutische formulierung und darin enthaltende liganden; uea-1 mimetika | |
WO2002036105A3 (en) | Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders | |
HUP0002459A3 (en) | Salts of optically active sulfoxide derivative, pharmaceutical compositions containing them and use thereof |